Project Details
Description
No summary available
Status | Finished |
---|---|
Effective start/end date | 1/04/06 → 31/10/11 |
Collaborative partners
- Ecole Normale Supérieure de Cachan (lead)
- Assistance publique - Hôpitaux de Paris
- BioAlliance Pharma SA
- BioReliance Ltd
- Commissariat à l'énergie atomique et aux énergies alternatives
- CellGenix Technologie Transfer GmbH
- Centre Hospitalier Universitaire de Nantes
- Clean Cells
- Centre National de Recherche Scientifique
- Epixis SA
- European Society of Gene Therapy
- Gesellshaft für Biotechnologische Forshung GmbH
- Généthon. Centre de Recherche et d'applications sur les thérapies géniques
- GenoSafe SAS
- IBET, Instituto de Biologia Experimental e Tecnológica
- Institute of Molecular Genetics AS CR
- Institut National de la Santé et de la Recherche Médicale
- Istituto Toscano Tumori (ITT)
- Karolinska Intitute
- Life Science Research Inc.
- Mayo Clinic
- Klinikum Rechts der Isar der Technischen Universitaet Muenchen
- Medizinische Hochschule Hannover
- Oxford BioMedica plc
- Bundesinstitut für Impfstoffe und Biomedizinische Arzneimittel (Paul-Ehrlich-Institut)
- Quintiles Ltd
- Royal Holloway and Bedford New College
- Fondazione Telethon (FTELE)
- Theravir Management L.P.
- Transgene S.A.
- UCL Institute of Ophthalmology
- Hebrew University of Jerusalem
- University of Innsbruck
- Universität zu Köln (Colònia)
- University of Kuopio
- Universitätsklinikum Ulm
- University of Lausanne
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.